Take the path forward with YESCARTA® CAR T-cell therapy

Cathy, YESCARTA patient


YESCARTA is a CAR T-cell therapy that is approved for adult patients with relapsed or refractory Large B-cell Lymphoma (LBCL) as a second-line therapy. If you are considering treatment options, this website can help you discover YESCARTA.


YESCARTA has been shown to help LBCL patients. A clinical trial compared YESCARTA to standard therapy* as a second-line treatment:

Patients icon.

A total of 359 adult patients were randomly assigned to one of two treatment groups. 180 patients received YESCARTA, and 179 patients received standard therapy.*

Icon with 2x text.

Two years after treatment, YESCARTA was more than twice as likely to help patients stay event-free (their LBCL didn't come back or get worse).

Circle icon with versus text.

*Standard therapy in this trial included chemoimmunotherapy, high-dose therapy, and autologous stem cell transplant, depending on how the cancer responded to treatment.

YESCARTA may cause side effects that are life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following:

  • Fever (100.4°F/38°C or higher)
  • Difficulty breathing
  • Chills or shaking chills
  • Confusion
  • Dizziness or lightheadedness
  • Severe nausea, vomiting, or diarrhea
  • Fast or irregular heartbeat
  • Severe fatigue or weakness

For patients who are starting or receiving treatment, please visit YESCARTA.com.

"Life is what you make of it and we all go down different paths... In my mind, I believe that I have, very fortunately, either chosen or been led down the right paths for me..."

MargaretYESCARTA patient

This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

Margaret, YESCARTA® (axicabtagene ciloleucel) patient ambassador.

This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

CAR T-cell therapy

CAR T-cell therapy, or CAR T, is a type of immunotherapy. In CAR T, your T cells are modified to recognize and attack certain cancer cells. This is done by modifying your T cells to have Chimeric Antigen Receptors (CARs). This turns them from T cells into CAR T cells.
A T cell modified to have CAR which then becomes a CAR T cell.
YESCARTA is one brand of CAR T. Different brands of CAR T may be approved to treat the same or different types of cancer. Talk to a CAR T specialist to understand what may be best for you.

Event-free survival

In clinical trials, an event is when a patient’s cancer comes back, gets worse, or experiences any other complications or worsening of symptoms.

Event-free means a patient has not experienced an event.

Event-free survival (EFS) measures the length of time after treatment that patients go without having an event. Researchers and doctors use event-free survival data to help determine how well a treatment works.

Relapsed or refractory

Relapsed means that the signs and symptoms of cancer have returned after having disappeared.

Refractory means that the cancer did not respond to treatment.

Second-line therapy

A treatment that is given after a first treatment (first-line therapy) did not work or stops working.

Approved Use

YESCARTA is a prescription medicine used to treat large B-cell lymphoma, a type of non-Hodgkin ...

Important Safety Information

What is the most important information I should know about YESCARTA? YESCARTA may cause side effects that are life-threatening and can lead to death ...

Approved Use and Important Safety Information

Approved Use

YESCARTA® is a prescription medicine used to treat large B-cell lymphoma, a type of non-Hodgkin lymphoma, when your first treatment did not work or your cancer returned within a year of first treatment.

YESCARTA is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.

Important Safety Information

What is the most important information I should know about YESCARTA?

YESCARTA may cause side effects that are life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following:

  • Fever (100.4°F/38°C or higher)
  • Difficulty breathing
  • Chills or shaking chills
  • Confusion
  • Dizziness or lightheadedness
  • Severe nausea, vomiting, or diarrhea
  • Fast or irregular heartbeat
  • Severe fatigue or weakness

It is important to tell your healthcare provider that you received YESCARTA. Your healthcare provider may give you other medicines to treat your side effects.

Before getting YESCARTA, tell your healthcare provider about all your medical problems, including if you have or have had:

  • Neurologic problems (such as seizures, stroke, or memory loss)
  • Lung or breathing problems
  • Heart problems
  • Liver problems
  • Kidney problems
  • A recent or active infection

Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive YESCARTA?

  • Since YESCARTA is made from your own white blood cells, your blood will be collected by a process called “leukapheresis” (loo-kah-fur-ee-sis), which will concentrate your white blood cells.
  • Your blood cells will be sent to a manufacturing center to make your YESCARTA.
  • Before you get YESCARTA, you will get 3 days of chemotherapy to prepare your body.
  • When your YESCARTA is ready, your healthcare provider will give it to you through a catheter placed into your vein (intravenous infusion). The infusion usually takes less than 30 minutes.
  • You will be monitored daily for at least 7 days after the infusion.
  • You should plan to stay close to a healthcare facility for at least 2 weeks after getting YESCARTA. Your healthcare provider will help you with any side effects that may occur.
  • You may be hospitalized for side effects and your healthcare provider will discharge you if your side effects are under control, and it is safe for you to leave the hospital.
  • Your healthcare provider will want to do blood tests to follow your progress. It is important that you do have your blood tested. If you miss an appointment, call your healthcare provider as soon as possible to reschedule.

What should I avoid after receiving YESCARTA?

  • Avoid driving for at least 2 weeks after you get YESCARTA.
  • Do not donate blood, organs, tissues, or cells for transplantation.

What are the possible or reasonably likely side effects of YESCARTA?

The most common side effects of YESCARTA include:

  • Fever (100.4°F/38°C or higher)
  • Low white blood cells (can occur with a fever)
  • Low red blood cells
  • Low blood pressure (dizziness or lightheadedness, headache, feeling tired, short of breath)
  • Fast heartbeat
  • Confusion
  • Difficulty speaking or slurred speech
  • Nausea
  • Diarrhea

YESCARTA may increase your risk of getting cancers including certain types of blood cancers. Your healthcare provider should monitor you for this.

These are not all the possible side effects of YESCARTA. Call your healthcare provider about any side effects that concern you. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Important Facts, including IMPORTANT WARNINGS.

You’ve reached the end of the Approved Uses and Important Safety Information. Click “Okay” to minimize the tray. You can reopen the full information at any time by clicking the “Read” button at the bottom of the screen.